Weekly Tesaro, Inc. (NASDAQ:TSRO) Ratings on May 17, 2018

May 17, 2018 - By Carol Mulligan

Tesaro, Inc. (NASDAQ:TSRO) Corporate Logo
During 2017 Q4 the big money sentiment decreased to 1.01. That’s change of 0.20, from 2017Q3’s 1.21. 46 investors sold all, 64 reduced holdings as Tesaro, Inc. ratio turned negative. 72 increased stakes while 39 funds took stakes. Funds hold 57.95 million shares thus 0.57% less from 2017Q3’s 58.28 million shares.
Whittier Trust accumulated 12,245 shs. Susquehanna Grp Llp holds 0.01% or 198,562 shs in its capital. Granite Point Capital L P holds 8,100 shs or 0.07% of its capital. Dupont Management Corporation holds 3,513 shs. Parallax Volatility Advisers Ltd Partnership has 0% invested in Tesaro, Inc. (NASDAQ:TSRO) for 8,943 shs. Macquarie Group accumulated 115,354 shs. 4,517 were accumulated by First Republic Investment Mgmt. Parametric Portfolio Assoc Lc owns 32,587 shs or 0% of their US capital. Kazazian Asset Mgmt Limited Company holds 7,806 shs or 0.66% of its capital. Fiera Capital owns 120,585 shs or 0.05% of their US capital. Bnp Paribas Arbitrage Sa invested 0% of its capital in Tesaro, Inc. (NASDAQ:TSRO). Rhumbline Advisers stated it has 39,477 shs or 0.01% of all its holdings. Two Sigma Securities Ltd Liability Com has 3,074 shs. Fmr Limited Liability Com, Massachusetts-based fund reported 8.03 million shs. Livforsakringsbolaget Skandia Omsesidigt accumulated 0.01% or 700 shs.

Tesaro, Inc. had 7 sales and 9 buys since March 1, 2018. This’s net activity of $61.19 million. $8.35M worth of Tesaro, Inc. (NASDAQ:TSRO) was bought by BASKETT FOREST on Friday, March 2. On Thursday, March 1 Bogle Grant C. also sold $99,224 worth of Tesaro, Inc. (NASDAQ:TSRO). On Friday, March 2 5,000 shs were bought by MOULDER LEON O JR, worth $284,640. BARRETT M JAMES had bought 116,445 shs worth $6.68 million on Friday, March 2. On Thursday, March 1 PEARSON TIMOTHY R sold $141,265 worth of Tesaro, Inc. (NASDAQ:TSRO) or 2,575 shs. $8.35M worth of Tesaro, Inc. (NASDAQ:TSRO) was bought by BARRIS PETER J on Friday, March 2.

Tesaro, Inc. (NASDAQ:TSRO) Ratings Coverage

In total 15 analysts cover Tesaro (NASDAQ:TSRO). “Buy” rating has 12, “Sell” are 0, while 3 are “Hold”. 80% are bullish. 18 are the (NASDAQ:TSRO)’s analyst reports since November 28, 2017 according to StockzIntelligence Inc. In Friday, May 4 report H.C. Wainwright maintained the stock with “Buy” rating. On Monday, April 16 the firm has “Hold” rating by Piper Jaffray given. In Friday, May 4 report Credit Suisse maintained it with “Outperform” rating and $128 target. On Tuesday, March 27 the stock of Tesaro, Inc. (NASDAQ:TSRO) has “Buy” rating given by Wedbush. On Wednesday, May 2 the firm has “Buy” rating given by Argus Research. On Wednesday, February 28 the firm has “Buy” rating by Wells Fargo given. On Wednesday, February 28 the stock has “Buy” rating by Leerink Swann. On Monday, May 7 the firm has “Buy” rating by Lake Street given. On Wednesday, February 28 the firm has “Outperform” rating by Credit Suisse given. On Thursday, March 1 the stock of Tesaro, Inc. (NASDAQ:TSRO) earned “Overweight” rating by Morgan Stanley. Listed here are Tesaro, Inc. (NASDAQ:TSRO) PTs and latest ratings.

07/05/2018 Broker: Lake Street Rating: Buy New Target: $80.0000 Maintain
04/05/2018 Broker: Bank of America Old Rating: Buy New Rating: Buy Old Target: $94 New Target: $88 Maintain
04/05/2018 Broker: Credit Suisse Old Rating: Outperform New Rating: Outperform Old Target: $141 New Target: $128 Maintain
04/05/2018 Broker: Citigroup Old Rating: Buy New Rating: Buy Old Target: $102 New Target: $100 Maintain
04/05/2018 Broker: H.C. Wainwright Rating: Buy New Target: $104.0000 Maintain
02/05/2018 Broker: Argus Research Old Rating: Buy New Rating: Buy Old Target: $154 New Target: $110 Maintain
16/04/2018 Broker: Piper Jaffray Rating: Hold Maintain
27/03/2018 Broker: Wedbush Rating: Buy New Target: $76.0000 Maintain
28/02/2018 Broker: Cowen & Co Rating: Hold New Target: $66.0 Maintain
01/03/2018 Broker: Morgan Stanley Old Rating: Overweight New Rating: Overweight Old Target: $156 New Target: $146 Maintain

The stock increased 3.47% or $1.7 during the last trading session, reaching $50.58.Tesaro, Inc. has volume of 673,653 shares. Since May 17, 2017 TSRO has declined 63.82% and is downtrending. TSRO underperformed the S&P500 by 75.37%.

Tesaro, Inc., an oncology-focused biopharmaceutical company, identifies, acquires, develops, and commercializes cancer therapeutics and oncology supportive care products in the United States.The firm is valued at $2.77 billion. It markets Rolapitant, a neurokinin-1, or NK-1, receptor antagonist for the prevention of chemotherapy induced nausea and vomiting under the VARUBI brand name.Currently it has negative earnings. The firm is also developing Niraparib, an orally active and potent poly polymerase inhibitor, which is in various clinical trials to treat ovarian or breast cancers.

A couple more Tesaro, Inc. (NASDAQ:TSRO) news were brought out by: Globenewswire.com which released on May 01, 2018 “TESARO Announces Participation in Two Investor Conferences”, also Streetinsider.com on May 16, 2018 brought out “TESARO (TSRO) Announces Presentations of Abstracts at ASCO”, the next Nasdaq.com is “TESARO Announces Presentations of Abstracts at the 2018 American Society of Clinical Oncology (ASCO) Annual …” on May 16, 2018. Globenewswire.com has article titled “TESARO Announces First-Quarter 2018 Operating Results”.

Tesaro, Inc. (NASDAQ:TSRO) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.